Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Multiple preclinical and phase I study results presented for AIT-082 at neuroscience meeting

Nov. 17, 1998

Series of nNOS inhibitors patented by Mitsui

Nov. 17, 1998

Potent and selective nicotinic acetylcholine receptor ligands prepared at Synthelabo

Nov. 17, 1998

Ultra-short-acting neuromuscular blockers with advantages over available agents

Nov. 17, 1998

Ono-1603 compared to tacrine for protection against age-induced neuronal apoptosis

Nov. 16, 1998

RJR-2403: CNS-selective nicotinic agonist with long-lasting beneficial effects on cognition

Nov. 16, 1998

Selective 5-HT7 receptor antagonist affects circadian rhythms in animal models

Nov. 16, 1998

Preclinical studies indicate OP-1 is effective three days after stroke

Nov. 16, 1998

SB team attempts to identify the source of antiparkinsonian activity of SKF-83959

Nov. 13, 1998

Neurobiological Technologies initiates phase IIb trial of memantine

Nov. 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.